Ranbaxy spinout gets $6.5M for N.J.-based generics biz
Bionpharma just raised $6.5 million, according to a regulatory filing - on top of about $31 million raised last year.
Bion Pharma, the startup launched by ex-Ranbaxy execs, raises $21M
Bion Pharma, the New Jersey startup freshly launched by a cadre of former execs from Indian generic drugmaker Ranbaxy, has raised $21 million from two investors, according to a regulatory filing. The company’s aiming to raise $30 million. Five execs at the U.S. branch of Ranbaxy quit last month, and aim through this Princeton-based startup to […]
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.